Article

$4 million in vision research funded via FY2009 defense appropriations

The federal government has allotted $4 million for peer-reviewed vision research via the fiscal year 2009 (FY2009) defense appropriations.

Washington, DC-The federal government has allotted $4 million for peer-reviewed vision research via the fiscal year 2009 (FY2009) defense appropriations. The U.S. Army will administer the funds, which will target the various causes, effects, and treatment of visual injuries resulting from exposures.

The passing of the final defense, military construction/veterans affairs, and homeland security spending bills-included in the continuing resolution passed by Congress and signed by President George W. Bush Sept. 30-marked the first time that peer-reviewed vision research appeared as a separate line item, according to the National Alliance for Eye and Vision Research (NAEVR). The bills funded the remaining government operations at the FY2008 level.

Vision formerly was one of 21 areas of research that could compete for a pool of $50 million of funds in the Peer Reviewed Medical Research Program.

“This unprecedented listing is a significant recognition by Congress about the need for defense-related vision research,” said James Jorkasky, executive director of NAEVR. The 501(c)4 non-profit advocacy coalition advocated for the dedicated funding and spent time educating House and Senate Defense Appropriations Subcommittee members about eye injuries experienced by soldiers in Iraq and Afghanistan.

Jorkasky said that the future of National Institutes of Health/National Eye Institute funding is uncertain, so the separate listing represents an important, dedicated vision-related research funding source in FY2009. As a result of the new earmark transparency policy, he added, NAEVR has estimated that FY2009 defense appropriations actually will fund about $20 million in vision-related research throughout the country.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.